Lantern Pharma Partners with New to The Street for National Exposure

New to The Street has announced a media partnership with Lantern Pharma Inc., a company at the forefront of AI-driven cancer medicine development. This collaboration involves a year-long campaign featuring national TV interviews, commercial ads, and high-profile media placements in New York City's Financial District and Times Square. The initiative aims to raise awareness among investors through non-deal roadshows across the U.S.

Lantern Pharma will gain exposure on New to The Street's syndicated broadcasts on Bloomberg Television and Fox Business Network, enhancing its visibility through digital and outdoor platforms. Vince Caruso, CEO of New to The Street, expressed enthusiasm for showcasing Lantern's innovative oncology pipeline.

Panna Sharma, CEO of Lantern Pharma, highlighted the partnership's alignment with their mission to advance cancer drug development using AI and data insights.